17:22MESO Mesoblast: hearing FDA Advisory Committee voted that available data do support the efficacy of remestemcel-L in pediatric patients with steroid-refractory aGVHD (halted) (11.81 +0.00)
Ryoncil: ODAC/FDA Meeting Discussion, page-1699
-
- There are more pages in this discussion • 348 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.000(0.00%) |
Mkt cap ! $1.370B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.18 | $2.392M | 2.002M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 19564 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 28296 | 7 |
View Market Depth
| Last trade - 11.24am 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |